Bicara Therapeutics Inc
Bicara Therapeutics Inc (BCAX) Implied Volatility Current
BCAX implied volatility is 61%. IV Rank is 11%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking BCAX implied volatility helps you identify when options premiums on Bicara Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Bicara Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when BCAX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Bicara Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For BCAX, tracking metrics like BCAX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on BCAX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where BCAX implied volatility sits today versus where it has been. Our scanner ranks Bicara Therapeutics Inc implied volatility against its historical range, surfaces extremes in BCAX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Bicara Therapeutics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track BCAX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→